Master Agreement for Clinical Trials Management ServicesMaster Agreement for Clinical Trials Management Services • May 10th, 2007 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
This Master Agreement for Clinical Trials Management Services (the “Agreement”) is made and entered into this 30th day of November, 2006, by and between CytRx Corporation, a corporation of California with offices at 11726 San Vicente Blvd., Los Angeles, CA 90049 (hereinafter referred to as “Sponsor”) and Pharmaceutical Research Associates, Inc., a corporation of the Commonwealth of Virginia, together with its Affiliates with offices at 12120 Sunset Hills Road, Suite 600, Reston, Virginia 20190 (hereinafter referred to as “PRA”), both hereinafter referred as “Parties”
AMENDMENT #1 TO THE MASTER AGREEMENT FOR CLINICAL TRIALS MANAGEMENT SERVICESMaster Agreement for Clinical Trials Management Services • October 14th, 2021 • Advaxis, Inc. • Pharmaceutical preparations
This Amendment #1 (“Amendment”), effective as of the 20th day of November, 2020, (the “Amendment Effective Date”), by and between Pharmaceutical Research Associates, Inc., together with its Affiliates, with offices at 4130 ParkLake Avenue, Suite 400, Raleigh, NC 27612, USA (hereinafter referred to as “PRA”) and Biosight Ltd., with offices at 1 Hayarden St., Airport City, P.O.B 1083 Lod 7019802, Israel (hereinafter referred to as “Sponsor”), both hereinafter referred as “Parties”.
Master Agreement for Clinical Trials Management ServicesMaster Agreement for Clinical Trials Management Services • October 14th, 2021 • Advaxis, Inc. • Pharmaceutical preparations • England and Wales
This Master Agreement for Clinical Trials Management Services (the “Agreement”) is made and entered into on May 3,2018 and effective as of November 20,2017, (the “Effective Date”), by and between Biosight Ltd., an Israeli corporation, with offices at 1 Hayarden St., Airport City, P.O.B 1083 Lod 7019802, Israel (hereinafter referred to as “Sponsor”) and Pharmaceutical Research Associates, Inc., a Commonwealth of Virginia corporation, together with its Affiliates, with offices at 4130 ParkLake Avenue, Suite 400, Raleigh, NC 27612 (hereinafter referred to as “PRA”), each hereinafter referred as “Party” and both hereinafter referred as “Parties”.
Master Agreement for Clinical Trials Management ServicesMaster Agreement for Clinical Trials Management Services • October 29th, 2009 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Master Agreement for Clinical Trials Management Services (the “Agreement”) is made and entered into on September 16, 2009, (the “Effective Date”), by and between Idenix Pharmaceuticals, Inc., with offices at 60 Hampshire Street, Cambridge, MA 02139, USA (hereinafter referred to as “Sponsor”) and Pharmaceutical Research Associates, Inc., a Commonwealth of Virginia corporation, together with its Affiliates, with offices at 4130 ParkLake Avenue, Suite 400, Raleigh, NC 27612 (hereinafter referred to as “PRA”), both hereinafter referred as "Parties".
